How do sympathomimetics and protease inhibitors (PIs) interact?

Updated: Jan 15, 2019
  • Author: Jason F Okulicz, MD, FACP, FIDSA; Chief Editor: Michelle R Salvaggio, MD, FACP  more...
  • Print


Coadministration of salmeterol with PIs is not recommended because of a potential increase in the risk of salmeterol-associated cardiovascular events, including QT prolongation, palpitations, and sinus tachycardia.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!